Corient Capital Partners’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,892	Closed	-$261K	–	765
2021 Q4	$261K	Buy	2,892 +333	+13%	+$30.1K	0.02%	569
2021 Q3	$237K	Buy	+2,559	New	+$237K	0.02%	581
2021 Q1	–	Sell	-1,213	Closed	-$206K	–	624
2020 Q4	$206K	Buy	+1,213	New	+$206K	0.02%	473